Amneal Pharmaceuticals (AMRX) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to -$54.4 million.
- Amneal Pharmaceuticals' Other Gross PP&E Adjustments rose 4953.07% to -$54.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$54.4 million, marking a year-over-year increase of 4953.07%. This contributed to the annual value of $914.7 million for FY2024, which is 189.52% up from last year.
- Per Amneal Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$54.4 million for Q3 2025, which was up 4953.07% from -$55.1 million recorded in Q2 2025.
- Over the past 5 years, Amneal Pharmaceuticals' Other Gross PP&E Adjustments peaked at $914.7 million during Q4 2024, and registered a low of -$192.6 million during Q1 2021.
- In the last 5 years, Amneal Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$109.4 million in 2021 and averaged $83.3 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 659.47% in 2024, then soared by 6872.72% in 2025.
- Amneal Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $842.8 million in 2021, then grew by 1.32% to $853.9 million in 2022, then rose by 5.12% to $897.6 million in 2023, then grew by 1.9% to $914.7 million in 2024, then crashed by 105.95% to -$54.4 million in 2025.
- Its Other Gross PP&E Adjustments was -$54.4 million in Q3 2025, compared to -$55.1 million in Q2 2025 and -$56.0 million in Q1 2025.